Stay updated on Pembrolizumab in SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.

Latest updates to the Pembrolizumab in SCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision label (v3.6.3) replacing the previous v3.6.2, indicating a deployment/update of the page build without altering study content.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page revision indicator was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor internal update to the page template or content.SummaryDifference0.1%

- Check35 days agoChange DetectedRecruitment status on the page now shows 'No longer looking for participants,' and the Intervention/Treatment label has been standardized. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check42 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, indicating a refreshed version of the page.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page content has been published.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page’s ClinicalTrials.gov interface revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.